| FSLBX | HILFX | FSLBX / HILFX | |
| Total Expense Ratio | 0.66 | 1.55 | 43% |
| Annual Report Gross Expense Ratio | 0.66 | 1.55 | 43% |
| Fund Existence | 41 years | 11 years | - |
| Gain YTD | -12.174 | -0.416 | 2,929% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 941M | 28.9M | 3,256% |
| Annual Yield % from dividends | 0.72 | 0.00 | - |
| Returns for 1 year | -7.75 | 5.11 | -152% |
| Returns for 3 years | 51.84 | 72.06 | 72% |
| Returns for 5 years | 55.69 | 7.07 | 788% |
| Returns for 10 years | 211.37 | 135.16 | 156% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WSTYX | 103.40 | 3.26 | +3.26% |
| Nomura Science and Technology Y | |||
| EMRSX | 27.37 | 0.82 | +3.09% |
| JPMorgan Emerging Mkts Rsrch Enh Eq R6 | |||
| GABVX | 12.51 | 0.04 | +0.32% |
| Gabelli Value 25 A | |||
| LSHAX | 28.19 | 0.09 | +0.32% |
| Kinetics Spin-Off and Corp Rest Adv A | |||
| MCVAX | 10.04 | -0.04 | -0.40% |
| Transamerica Mid Cap Value Opps A | |||